MariMed Inc. (OTCMKTS:MRMD – Get Free Report) was the recipient of a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 44,669 shares, a growth of 112.7% from the August 31st total of 20,999 shares. Based on an average daily trading volume, of 769,089 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are short sold.
MariMed Stock Up 2.0%
MRMD stock opened at $0.07 on Wednesday. The business’s 50-day moving average price is $0.07 and its 200-day moving average price is $0.07. The stock has a market cap of $30.22 million, a P/E ratio of -1.88 and a beta of 1.35. The company has a quick ratio of 0.34, a current ratio of 0.92 and a debt-to-equity ratio of 1.78. MariMed has a twelve month low of $0.06 and a twelve month high of $0.18.
MariMed (OTCMKTS:MRMD – Get Free Report) last released its earnings results on Wednesday, August 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). MariMed had a negative net margin of 9.13% and a negative return on equity of 10.71%. The company had revenue of $41.92 million during the quarter, compared to analyst estimates of $39.80 million.
About MariMed
MariMed, Inc is a U.S. cannabis company that develops, operates and manages regulated cannabis cultivation, processing and retail facilities. The company follows a vertically integrated business model, producing cannabis products and selling them through its own dispensaries and other authorized channels.
MariMed offers a range of cannabis products, including flower, pre-rolls, concentrates, edibles, tinctures and topical products. Its portfolio includes brands such as Betty’s Eddies, Nature’s Heritage, Bubby’s Baked and Kalm Fusion, which are marketed for recreational and medical-use consumers where permitted by state law.
The company serves regulated cannabis markets in several states, including Delaware, Maryland, Massachusetts and Ohio.
See Also
- Five stocks we like better than MariMed
- CarMax Just Gave Investors a Better Reason to Believe in the Turnaround
- CoreWeave Comes With Risks: Analysts Split on What Matters Most
- Bottlenecking the Future: TSMC Prices Out the Competition
- Fervo Energy Hits Geothermal Milestone: Will It Matter For The Stock?
Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.
